Literature DB >> 21981903

[When should specific pharmacological treatment be stopped in Alzheimer's?].

Gabriel Coll-de-Tuero1, Secundino López-Pousa, Joan Vilalta-Franch.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21981903      PMCID： PMC7025133          DOI： 10.1016/j.aprim.2011.09.001

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  15 in total

Review 1.  [Memantine: the value of combined therapy].

Authors:  J L Molinuevo
Journal:  Rev Neurol       Date:  2011-01-16       Impact factor: 0.870

Review 2.  The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.

Authors:  Jaclyn Cappell; Nathan Herrmann; Stephen Cornish; Krista L Lanctôt
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  [Annual economic cost of informal care in Alzheimer's disease].

Authors:  Oriol Turró-Garriga; Secundino López-Pousa; Joan Vilalta-Franch; Antoni Turon-Estrada; Imma Pericot-Nierga; Manuela Lozano-Gallego; Marta Hernández-Ferràndiz; Olga Soler-Cors; Xènia Planas-Pujol; Silvia Monserrat-Vila; Josep Garre-Olmo
Journal:  Rev Neurol       Date:  2010-08-16       Impact factor: 0.870

Review 4.  Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.

Authors:  Cesare Mancuso; Raffaella Siciliano; Eugenio Barone; David Allan Butterfield; Paolo Preziosi
Journal:  Expert Opin Investig Drugs       Date:  2011-08-02       Impact factor: 6.206

5.  Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Lon S Schneider; Philip S Insel; Michael W Weiner
Journal:  Arch Neurol       Date:  2011-01

6.  Disease-modifying treatments for Alzheimer's disease.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

7.  The rapid disability rating scale-2.

Authors:  M W Linn; B S Linn
Journal:  J Am Geriatr Soc       Date:  1982-06       Impact factor: 5.562

8.  A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients).

Authors:  R Spiegel; C Brunner; D Ermini-Fünfschilling; A Monsch; M Notter; J Puxty; L Tremmel
Journal:  J Am Geriatr Soc       Date:  1991-04       Impact factor: 5.562

9.  Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.

Authors:  Katie Palmer; Federica Lupo; Roberta Perri; Giovanna Salamone; Lucia Fadda; Carlo Caltagirone; Massimo Musicco; Luca Cravello
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

10.  [Cost relation between severity of Alzheimer's disease and cognitive and functional impairment].

Authors:  Secundino López-Pousa; Josep Garre-Olmo; Antoni Turon-Estrada; Francisco Hernández; Inmaculada Expósito; Manoli Lozano-Gallego; Marta Hernández-Ferrándiz; Esther Gelada-Batlle; Imma Pericot-Nierga; Joan Vilalta-Franch
Journal:  Med Clin (Barc)       Date:  2004-05-29       Impact factor: 1.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.